121 completed, 27 terminated, 17 unknown, 7 withdrawn. 175 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 175 | Completed 121, Terminated 27, Unknown 17, Withdrawn 7, Recruiting 2, Active not recruiting 1 |
Follow Sugars: new trials by email Literature Review of Sugars trials Research Report on Sugars
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Role Of Sensitivity to neuroEndocrine Systems in Social Decisions Hydrocortisone, Yohimbine, Placebo - Borderline Personality Disorder | Phase 4 | Withdrawn | University of North Carolina, Chapel Hill | 2024-07-01 | 2024-06-05 | |
| Beta-Blocker Influences on Inflammatory and Neural Responses to Stress Propranolol, Placebo - Cardiovascular Disease | Phase 4 | Recruiting | University of North Carolina, Chapel Hill | 120 | 2024-05-01 | 2026-11-05 |
| Over-the-Counter Antihistamines & Heat Stress 50 mg Diphenhydramine, 10 mg Loratadine, 5 mg Desloratadine - Heat Illness, Allergic Rhinitis | Phase 4 | Unknown | Lakehead University | 16 | 2023-12-05 | 2024-01-22 |
| The Effect of NAD Supplementation on Brain Vascular Health in Aging Nicotinamide riboside, Placebo - Aging | Phase 4 | Recruiting | University of Oklahoma | 214 | 2023-05-03 | 2026-04-01 |
| Duloxetine Tibial Plateau Duloxetine, Placebo, Standard of care (SOC) for tibial plateau surgery - Tibial Plateau Fracture, Pain, Postoperative | Phase 4 | Withdrawn | Boston Medical Center | 2022-10-01 | 2022-11-21 | |
| Brain and Stress Study Minocycline, Placebo - Stress, Psychological, Motivation | Phase 4 | Completed | University of North Carolina, Chapel Hill | 10 | 2022-09-12 | 2024-12-18 |
| Sublingual Apomorphine in Refractory Restless Legs Syndrome Apomorphine Sublingual Film, Placebo - Restless Legs Syndrome | Phase 4 | Unknown | William Ondo, MD | 16 | 2022-09-01 | 2022-09-06 |
| Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study Amiodarone Hydrochloride, Placebo - Atrial Fibrillation | Phase 4 | Terminated | University of Calgary | 3 | 2022-02-03 | 2026-02-05 |
| Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach Estradiol Transdermal Patch 0.1 mg/24 hrs, Oral Micronized Progesterone 200mg, Inactive Clear Patch - Suicidal Ideation | Phase 4 | Completed | University of Illinois at Chicago | 124 | 2020-09-15 | 2025-12-19 |
| Effects of Tetrahydrobiopterin (BH4) on Leg Blood Flow and Exercise Capacity in Patients With Peripheral Artery Disease Sapropterin Dihydrochloride (BH4, tetrahydrobiopterin), Placebo - Peripheral Artery Disease, Peripheral Arterial Disease | Phase 4 | Withdrawn | University of Nebraska | 2019-07-01 | 2024-09-03 | |
| Evaluation of the Effects of Pre-operative Deflazacort on Post-operative Pain, Edema and Trismus Deflazacort 30 MG Oral Tablet, Sugar pill - Impacted Third Molar Tooth | Phase 4 | Unknown | Yuzuncu Yil University | 35 | 2018-12-15 | 2023-08-22 |
| The Effect of Tablet Size on Cognitive Performance Caffeine Caffeine Anhydrous with small sucrose pill, Placebo - large sucrose pill, Caffeine Anhydrous with large sucrose pill - Placebo Effect | Phase 4 | Completed | University of Colorado, Denver | 120 | 2018-10-31 | 2019-04-17 |
| Brain Perfusion & Oxygenation in Parkinson's Disease With NOH Droxidopa, Placebo - Parkinson Disease, Neurogenic Orthostatic Hypotension | Phase 4 | Completed | William Ondo, MD | 17 | 2018-08-23 | 2022-09-06 |
| Unique Effects of Perimenstrual Estradiol or Progesterone Supplementation on Perimenstrual Suicidality Transdermal Estradiol + Placebo, Oral Micronized Progesterone + Placebo, Placebos - Suicidal Ideation | Phase 4 | Completed | University of Illinois at Chicago | 60 | 2018-07-27 | 2022-09-14 |
| Effect of Combined Morphine and Duloxetine on Chronic Pain Morphine, Duloxetine, Placebo - Chronic Low Back Pain, Chronic Neck Pain | Phase 4 | Completed | Massachusetts General Hospital | 81 | 2018-03-12 | 2024-11-14 |
| IMProving Executive Function Study Lisdexamfetamine, Placebo oral capsule - Cognitive Impairment, RRSO | Phase 4 | Completed | University of Pennsylvania | 69 | 2017-09-22 | 2023-11-18 |
| Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's Disease Mirabegron, Placebo - Overactive Bladder, Parkinson Disease | Phase 4 | Unknown | Seoul National University Hospital | 144 | 2017-07-17 | 2018-01-30 |
| Effects of Delta-9 Tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R61 Study Placebo Oral Capsule, Dronabinol Cap 5 milligrams (MG), Dronabinol Cap 10 milligrams (MG) - PostTraumatic Stress Disorder | Phase 4 | Completed | Wayne State University | 46 | 2017-06-01 | 2025-08-22 |
| A Study of Suvorexant in Patients With Multiple Sclerosis Fatigue and Insomnia Suvorexant, Placebo - Multiple Sclerosis, Fatigue | Phase 4 | Completed | Theodore R. Brown, MD MPH | 36 | 2017-03-28 | 2025-02-03 |
| Naloxegol for the Prevention of Constipation in Postoperative Spinal Surgery Patients MOVANTIK⢠(naloxegol), Sugar Pill - Constipation | Phase 4 | Terminated | Massachusetts General Hospital | 53 | 2017-01-01 | 2019-09-10 |
Showing 20 of 175. Sign in to see all of them.
Depression (13) · Pain (10) · Bipolar Disorder (9) · Obesity (8) · Parkinson Disease (8) · Attention Deficit Disorder with Hyperactivity (7) · Schizophrenia (7) · Alcoholism (6) · Depressive Disorder, Major (6) · Psychotic Disorders (6) · Stress Disorders, Post-Traumatic (6) · Cognitive Dysfunction (5) · Fatigue (5) · Sleep Initiation and Maintenance Disorders (5) · Agnosia (4)
University of North Carolina, Chapel Hill (7) · Massachusetts General Hospital (6) · New York State Psychiatric Institute (6) · University of Texas Southwestern Medical Center (6) · Northwestern University (4) · Johns Hopkins University (3) · University of California, San Francisco (3) · University of Colorado, Denver (3) · University of Illinois at Chicago (3) · University of Michigan (3) · University of Nebraska (3) · University of Pennsylvania (3) · Dr. Stephen Freedman (2) · M.D. Anderson Cancer Center (2) · NYU Langone Health (2)
United States (133) · Canada (9) · Australia (3) · Norway (3) · United Kingdom (3) · Austria (2) · China (2) · Pakistan (2) · South Korea (2) · Finland (1) · France (1) · Israel (1) · Mexico (1) · Singapore (1) · Sweden (1)
Apkar Apkarian, PhD (2) · Donald C Goff, MD (2) · Keely Muscatell, PhD (2) · Peter D Reaven, MD (2) · Sajid B Soofi, MD (2) · Sherwood Brown, MD, PhD (2) · Stephen Freedman, MD (2) · Tory A Eisenlohr-Moul, PhD (2) · William Ondo, MD (2) · Zulfiqar Bhutta, MD (2) · Abdulla K. Salahudeen, MD (1) · Ahmad M Slim, MD (1) · Andrew A. Nierenberg, M.D. (1) · Andrew D Goodman, MD (1) · Andrew Miller, MD (1)
PMID 34433773, PMID 36269595, PMID 36999619, PMID 37142273, PMID 10598635, PMID 12670812, PMID 15275765, PMID 16679671, PMID 17251278, PMID 18700421, PMID 19577749, PMID 20492840, PMID 21346734, PMID 21777715, PMID 21923696, PMID 22353759, PMID 22393222, PMID 23186950, PMID 23575741, PMID 23788218, PMID 23870503, PMID 24290461, PMID 24345758, PMID 24606117, PMID 24890531, PMID 25760804, PMID 25970252, PMID 25998279, PMID 26063677, PMID 26115513, PMID 26227019, PMID 26237520, PMID 26351969, PMID 26414990, PMID 26731446, PMID 26745211, PMID 27117285, PMID 27550732, PMID 27733180, PMID 27788130, PMID 28012485, PMID 28652290, PMID 28778815, PMID 28861338, PMID 29030421, PMID 29432967, PMID 29478970, PMID 29588126, PMID 29671676, PMID 29773079
R01AT007987 (2), R01MH072383 (2), 2009 (1), 2015 (1), I21RX002180 (1), K23DK106520 (1), K23HL093214 (1), K23HL119602 (1), K99MH109667 (1), P50HL084945 (1), P50NS062684 (1), P60AA003510 (1), R00MH102349 (1), R00MH109667 (1), R01AA013379 (1)